PCA
BSX icon

Personal Capital Advisors’s Boston Scientific BSX Stock Holding History

Personal Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$573K Buy
12,376
+2,151
+21% +$93.1K ﹤0.01% 283
2022
Q3 		$396K Buy
10,225
+2,265
+28% +$90.9K ﹤0.01% 317
2022
Q2 		$297K Buy
7,960
+53
+0.7% +$2.16K ﹤0.01% 354
2022
Q1 		$350K Sell
7,907
-1,634
-17% -$70.8K ﹤0.01% 356
2021
Q4 		$402K Buy
9,541
+1,245
+15% +$52.3K ﹤0.01% 373
2021
Q3 		$360K Buy
8,296
+2,315
+39% +$102K ﹤0.01% 362
2021
Q2 		$256K Buy
5,981
+17
+0.3% +$715 ﹤0.01% 424
2021
Q1 		$231K Sell
5,964
-799
-12% -$30.2K ﹤0.01% 439
2020
Q4 		$243K Sell
6,763
-254
-4% -$9.15K ﹤0.01% 418
2020
Q3 		$268K Sell
7,017
-232
-3% -$8.94K ﹤0.01% 352
2020
Q2 		$255K Buy
7,249
+99
+1% +$3.56K ﹤0.01% 314
2020
Q1 		$233K Sell
7,150
-1,869
-21% -$73K ﹤0.01% 315
2019
Q4 		$408K Buy
9,019
+1,790
+25% +$74.9K ﹤0.01% 288
2019
Q3 		$294K Buy
7,229
+119
+2% +$5.04K ﹤0.01% 297
2019
Q2 		$306K Buy
7,110
+327
+5% +$12.6K ﹤0.01% 272
2019
Q1 		$260K Buy
6,783
+9
+0.1% +$344 ﹤0.01% 286
2018
Q4 		$239K Sell
6,774
-106
-2% -$3.84K ﹤0.01% 278
2018
Q3 		$265K Sell
6,880
-60
-0.9% -$2.1K ﹤0.01% 258
2018
Q2 		$227K Sell
6,940
-2,424
-26% -$73.1K ﹤0.01% 263
2018
Q1 		$256K Buy
+9,364
New +$255K ﹤0.01% 237
2014
Q2 		– Sell
-10,000
Closed -$135K – 88
2014
Q1 		$135K Buy
+10,000
New +$131K 0.03% 87

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Personal Capital Advisors's BSX Position: Q4 2022 in Review

Personal Capital Advisors increased its Boston Scientific (BSX) stake by 21% in Q4 2022, buying an estimated $93.1K and bringing the position to 12,376 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Personal Capital Advisors first reported a position in BSX in Q1 2014 and has held it in 21 quarters since. 930 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Personal Capital Advisors held 12,376 shares of Boston Scientific worth $573K as of Q4 2022.
  • Personal Capital Advisors bought 2,151 Boston Scientific shares in Q4 2022, an estimated $93.1K.
  • Boston Scientific made up ﹤0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #283 holding.
  • Personal Capital Advisors first reported a position in Boston Scientific in Q1 2014 and has held it in 21 quarters since.
  • 930 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.